Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report

Antonio Cuneo, Lydia Scarfò, Gianluigi Reda, Marzia Varettoni, Francesca Maria Quaglia, Monia Marchetti, Lorenzo De Paoli, Francesca Re, Daniela Pietrasanta, Gian Matteo Rigolin, Lorella Orsucci, Adalberto Ibatici, Valter Gattei, Francesca R. Mauro, Livio Trentin, Luca Laurenti, Roberto Marasca, Robin Foà

Blood (2020) 136 (6): 763–766.

https://doi.org/10.1182/blood.2020006854

Published: 2020

Journal Articles

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Blood (2020) 135 (21): 1859–1869.

https://doi.org/10.1182/blood.2019003453

Published: 2020

Includes: Supplemental data

Journal Articles

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients

Blood (2016) 128 (16): 2093–2095.

https://doi.org/10.1182/blood-2016-07-728261

Published: 2016

Includes: Supplemental data

Journal Articles

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Blood (2015) 126 (16): 1921–1924.

https://doi.org/10.1182/blood-2015-05-647925

Published: 2015

Includes: Supplemental data

Journal Articles

Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness

Monica Messina, Ilaria Del Giudice, Hossein Khiabanian, Davide Rossi, Sabina Chiaretti, Silvia Rasi, Valeria Spina, Antony B. Holmes, Marilisa Marinelli, Giulia Fabbri, Alfonso Piciocchi, Francesca R. Mauro, Anna Guarini, Gianluca Gaidano, Riccardo Dalla-Favera, Laura Pasqualucci, Raul Rabadan, Robin Foà

Blood (2014) 123 (15): 2378–2388.

https://doi.org/10.1182/blood-2013-10-534271

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical Relevance of an Extended Diagnostic Work-Out in Patients with Primary Autoimmune Amolytic Anemia (AIHA)

Francesca R Mauro, MD, PhD, Daniele Armiento, MD, Serelina Coluzzi, MD, Maria S De Propris, PhD, Francesca Paoloni, BS, Gianluca Giovannetti, MD, Matteo Molica, MD, Luisa Quattrocchi, MD, Michelina Santopietro, MD, Chiara Spadafora, Lucia Granati, MD, Mara Riminucci, MD, Anna Guarini, PhD, Gabriella Girelli, MD, Robin Foà, MD

Blood (2012) 120 (21): 3192.

https://doi.org/10.1182/blood.V120.21.3192.3192

Published: 2012

Journal Articles

Role of PET/CT in the Diagnostic Work-up of Patients with Chronic Lymphocytic Leukemia (CLL) and Clinical Signs of Disease Progression

Francesca R Mauro, MD, PhD, Mara Riminucci, MD, Davide Rossi, MD, PhD, Francesca Paoloni, BS, Luca Laurenti, MD, Anna M Frustaci, MD, Giuseppe Cimino, MD, Michelina Santopietro, MD, Chiara Spadafora, Angela Rago, M.D., Francesco Autore, MD, Molica Matteo, MD, Brocchieri Simonetta, MD, Emanuele Nicolai, MD, Gianluca Gaidano, MD, PhD, Anna Guarini, PhD, Bianco Paolo, MD, Robin Foà, MD

Blood (2012) 120 (21): 3888.

https://doi.org/10.1182/blood.V120.21.3888.3888

Published: 2012

Journal Articles

Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL

Dalemari Crowther-Swanepoel, Ruth Wild, Gabrielle Sellick, Martin J. S. Dyer, Francesca R. Mauro, Robert J. G. Cuthbert, Viggo Jonsson, Estella Matutes, Claire Dearden, James Wiley, Stephen Fuller, Daniel Catovsky, Richard S. Houlston

Blood (2008) 111 (12): 5691–5693.

https://doi.org/10.1182/blood-2008-03-142349

Published: 2008

Journal Articles

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Simona Tavolaro, BS, Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Franca Citarella, PhD, Simona Santangelo Miss, Marilisa Marinelli, BS, Maria R. Ricciardi, PhD, Maria S. De Propris, PhD, Ilaria Del Giudice, MD, PhD, Francesca R. Mauro, MD, Sabina Chiaretti, MD, PhD, Robert Foa, MD, Anna Guarini, PhD

Blood (2007) 110 (11): 1133.

https://doi.org/10.1182/blood.V110.11.1133.1133

Published: 2007

Journal Articles

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Nadia Peragine, BS, Roberta Maggio, BS, Ilaria Del Giudice, MD, PhD, Emanuela M. Ghia, PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 3117.

https://doi.org/10.1182/blood.V110.11.3117.3117

Published: 2007

Journal Articles

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Gabrielle S. Sellick, Lynn R. Goldin, Ruth W. Wild, Susan L. Slager, Laura Ressenti, Sara S. Strom, Martin J. S. Dyer, Francesca R. Mauro, Gerald E. Marti, Stephen Fuller, Matthew Lyttelton, Thomas J. Kipps, Michael J. Keating, Timothy G. Call, Daniel Catovsky, Neil Caporaso, Richard S. Houlston

Blood (2007) 110 (9): 3326–3333.

https://doi.org/10.1182/blood-2007-05-091561

Published: 2007

Journal Articles

Fludarabine, Ara-C, Novantrone and Dexamethasone Plus Campath-1H for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) and Adverse Clinical and Biologic Prognostic Features.

Francesca R. Mauro, MD, Elena Giammartini, MD, Maria S. De Propris, BD, Giuseppe Gentile, MD, Mauro Nanni, BD, Emanuela M. Ghia, BD, Irene Della Starza, BD, Ilaria Del Giudice, MD, Simona Santangelo, BD, Marilisa Marinelli, BD, Fulvia Brugnoletti, MD, Clara Minotti, MD, Vera Capria, MD, Anna Guarini, BD, Robert Foa, MD

Blood (2006) 108 (11): 2830.

https://doi.org/10.1182/blood.V108.11.2830.2830

Published: 2006

Journal Articles

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Francesca R. Mauro, MD, Ilaria Del Giudice, MD PhD, Roberta Maggio, BS, Emanuela M. Ghia, BS, Marilisa Marinelli, BS, Simona Santangelo Miss, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2794.

https://doi.org/10.1182/blood.V108.11.2794.2794

Published: 2006

Journal Articles

Histopathologic and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis Challenging the Benign Nature of the Disorder.

Ilaria Del Giudice, MD, PhD, Stefano A. Pileri, MD, Maura Rossi, BTD, Elena Sabattini, MD, Cristina Campidelli, MD, Irene Della Starza Miss, Stefania M. De Propris, PhD, Francesca Mancini, PhD, Francesca R. Mauro, MD, Agostino Tafuri, MD, Luisa Bizzoni, MD, Angela Rago, MD, Angela Amendola, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 4612.

https://doi.org/10.1182/blood.V108.11.4612.4612

Published: 2006

Journal Articles

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Sabina Chiaretti, MD, PhD, Valerio Fulci, PhD, Marina Goldoni, BS, Gianluca Azzalin, Mr, Simona Tavolaro, BS, Monica Messina, BS, Roberta Maggio, BS, Nadia Peragine, BS, Simona Santangelo Miss, Francesca R. Mauro, MD, Anna Guarini, PhD, Giuseppe Macino, PhD, Robert Foa, MD

Blood (2006) 108 (11): 298.

https://doi.org/10.1182/blood.V108.11.298.298

Published: 2006

Journal Articles

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Sabina Chiaretti, MD PhD, Stefania M. De Propris, PhD, Simona Tavolaro, BS, Marilisa Marinelli, BS, Elisabetta Calabrese, BS, Ilaria Del Giudice, MD PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2819.

https://doi.org/10.1182/blood.V108.11.2819.2819

Published: 2006

Journal Articles

Chronic Lymphocytic Leukemia (CLL) with Discordance in ZAP-70 Expression and IgVH Mutation Status.

Ilaria Del Giudice, MD, PhD, Emanuela M. Ghia, BS, Stefania M. De Propris, PhD, Marilisa Marinelli, BS, Mauro Nanni, PhD, Francesca Mancini, PhD, Massimo Gentile, MD, Elena Giammartini, MD, Elisabetta Calabrese, MD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2787.

https://doi.org/10.1182/blood.V108.11.2787.2787

Published: 2006

Journal Articles

Relationship between Autoimmune Phenomena and Disease Stage and Therapy in B-Cell Chronic Lymphocytic Leukaemia.

Wilma Barcellini, MD, Silvana Capalbo, MD, Rosa M. Agostinelli, MD, Francesca R. Mauro, MD, Achille Ambrosetti, MD, Rossella Calori, MD, Agostino Cortelezzi, MD, Luca Laurenti, MD, Enrico M. Pogliani, MD, Paola Pedotti, MD, Vincenzo Liso, MD, Franco Mandelli, MD, Alberto Zanella, MD

Blood (2006) 108 (11): 4929.

https://doi.org/10.1182/blood.V108.11.4929.4929

Published: 2006

Journal Articles

Chronic Lymphocytic Leukemia (CLL) in Parents and Children.

Francesca R. Mauro, MD, Emanuela M. Ghia, BD, Maria S. De Propris, BD, Elena Giammartini, MD, Irene Della Starza, BD, Diana Giannarelli, BSc, Ilaria Del Giudice, MD, Simona Santangelo, BD, Fulvia Brugnoletti, MD, Massimo Gentile, MD, Anna Guarini, BD, Robert Foa, MD

Blood (2006) 108 (11): 4935.

https://doi.org/10.1182/blood.V108.11.4935.4935

Published: 2006

Journal Articles

Follow-Up of Chronic Lymphocytic Leukemia (CLL) Patients Who Relapse after Autologous Stem Cell Transplantation (ASCT).

Silvia M. Trisolini, MD, Francesca R. Mauro, MD, Saveria Capria, MD, Giuseppe Cimino, MD, Maria S. De Propris, Phd, Anna Proia, MD, Robin Foà, Giovanna Meloni, MD

Blood (2004) 104 (11): 5212.

https://doi.org/10.1182/blood.V104.11.5212.5212

Published: 2004

NARROW

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness

Clinical Relevance of an Extended Diagnostic Work-Out in Patients with Primary Autoimmune Amolytic Anemia (AIHA)

Role of PET/CT in the Diagnostic Work-up of Patients with Chronic Lymphocytic Leukemia (CLL) and Clinical Signs of Disease Progression

Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Fludarabine, Ara-C, Novantrone and Dexamethasone Plus Campath-1H for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) and Adverse Clinical and Biologic Prognostic Features.

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Histopathologic and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis Challenging the Benign Nature of the Disorder.

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Chronic Lymphocytic Leukemia (CLL) with Discordance in ZAP-70 Expression and IgVH Mutation Status.

Relationship between Autoimmune Phenomena and Disease Stage and Therapy in B-Cell Chronic Lymphocytic Leukaemia.

Chronic Lymphocytic Leukemia (CLL) in Parents and Children.

Follow-Up of Chronic Lymphocytic Leukemia (CLL) Patients Who Relapse after Autologous Stem Cell Transplantation (ASCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only